DERM
$1.76
Journey Medical
($.05)
(2.76%)
DERM
Earnings Whisper ®
N/A
2nd Quarter June 2023
Consensus:  ($0.34)
Revenue:  $15.07 Mil
Monday
Aug 21
4:00 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when DERM reports earnings?
Beat
Meet
Miss

Where is DERM's stock price going from here?
Up
Flat
Down
Stock chart of DERM
Analysts
Summary of analysts' recommendations for DERM
Score
Grade
Pivots
Resistance
$2.33
$2.14
$1.98

$1.79

Support
$1.63
$1.44
$1.28
Tweet
Growth
Description
Journey Medical Corporation is a commercial-stage pharmaceutical company. It focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Journey Medical Corporation is based in Scottsdale, Arizona.
Peers
Vertex PharmaceuticalsBioMarin PharmaceuticalRegeneron PharmaceuticalsJohnson & JohnsonEli LillyMerck & Co.Bristol-Myers SquibbArray TechnologiesUltragenyx PharmaceuticalPfizer
›